Literature DB >> 16610014

Role of Toll-like receptors in health and diseases of gastrointestinal tract.

Greg Harris, Rhonda KuoLee, Wangxue Chen.   

Abstract

The human gastrointestinal (GI) tract is colonized by non-pathogenic commensal microflora and frequently exposed to many pathogenic organisms. For the maintenance of GI homeostasis, the host must discriminate between pathogenic and non-pathogenic organisms and initiate effective and appropriate immune and inflammatory responses. Mammalian toll-like receptors (TLRs) are members of the pattern-recognition receptor (PRR) family that plays a central role in the initiation of innate cellular immune responses and the subsequent adaptive immune responses to microbial pathogens. Recent studies have shown that gastrointestinal epithelial cells express almost all TLR subtypes characterized to date and that the expression and activation of TLRs in the GI tract are tightly and coordinately regulated. This review summarizes the current understanding of the crucial dual roles of TLRs in the development of host innate and adaptive immune responses to GI infections and the maintenance of the immune tolerance to commensal bacteria through down-regulation of surface expression of TLRs in intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610014      PMCID: PMC4087639          DOI: 10.3748/wjg.v12.i14.2149

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  154 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 2.  Toll-like receptors in health and disease: complex questions remain.

Authors:  Ian Sabroe; Robert C Read; Moira K B Whyte; David H Dockrell; Stefanie N Vogel; Steven K Dower
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

3.  Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.

Authors:  P M Chaudhary; C Ferguson; V Nguyen; O Nguyen; H F Massa; M Eby; A Jasmin; B J Trask; L Hood; P S Nelson
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

4.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

5.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

Authors:  D M Underhill; A Ozinsky; K D Smith; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB.

Authors:  N Inohara; T Koseki; L del Peso; Y Hu; C Yee; S Chen; R Carrio; J Merino; D Liu; J Ni; G Núñez
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

7.  Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis.

Authors:  P J Sansonetti; J Arondel; M Huerre; A Harada; K Matsushima
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Bacterial invasion is not required for activation of NF-kappaB in enterocytes.

Authors:  T Eaves-Pyles; C Szabó; A L Salzman
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Authors:  S T Qureshi; L Larivière; G Leveque; S Clermont; K J Moore; P Gros; D Malo
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  24 in total

1.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

Review 2.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

3.  Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia.

Authors:  Isabella Barajon; Graziano Serrao; Francesca Arnaboldi; Emanuela Opizzi; Gerlomina Ripamonti; Andrea Balsari; Cristiano Rumio
Journal:  J Histochem Cytochem       Date:  2009-06-22       Impact factor: 2.479

Review 4.  Wound healing of intestinal epithelial cells.

Authors:  Masahiro Iizuka; Shiho Konno
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

5.  Effect of supplemental yeast cell walls on growth performance, gut mucosal glutathione pathway, proteolytic enzymes and transporters in growing broiler chickens.

Authors:  Ning Liu; Jinquan Wang; Zhaoyang Liu; Yongchao Wang; Jianping Wang
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

6.  GanedenBC30 cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro.

Authors:  Gitte S Jensen; Kathleen F Benson; Steve G Carter; John R Endres
Journal:  BMC Immunol       Date:  2010-03-24       Impact factor: 3.615

Review 7.  Toll-like receptors in skin infections and inflammatory diseases.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Infect Disord Drug Targets       Date:  2008-09

8.  Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.

Authors:  Alexandra Zhernakova; Eleanora M Festen; Lude Franke; Gosia Trynka; Cleo C van Diemen; Alienke J Monsuur; Marianna Bevova; Rian M Nijmeijer; Ruben van 't Slot; Roel Heijmans; H Marike Boezen; David A van Heel; Adriaan A van Bodegraven; Pieter C F Stokkers; Cisca Wijmenga; J Bart A Crusius; Rinse K Weersma
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

9.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020

10.  Multivariate inference of pathway activity in host immunity and response to therapeutics.

Authors:  Gautam Goel; Kara L Conway; Martin Jaeger; Mihai G Netea; Ramnik J Xavier
Journal:  Nucleic Acids Res       Date:  2014-08-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.